Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
9 July 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
30 June 2020
A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models
26 June 2020
Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development